首页> 美国卫生研究院文献>ACS Medicinal Chemistry Letters >Synthesis and in Vitro Evaluationof Stabilized and Selective Neuromedin U-1 Receptor Agonists
【2h】

Synthesis and in Vitro Evaluationof Stabilized and Selective Neuromedin U-1 Receptor Agonists

机译:合成与体外评估和选择性的神经介素U-1受体激动剂的合成

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Neuromedin U (NMU) is a multifunctional neuropeptide which is characterized by a high conservation through all species. Herein, we describe the synthesis of a novel set of NMU-analogs based on the truncated NMU-8. Through combination of previously reported modifications, an elaborate structure–activity relationship study was performed aiming for the development of peptides with an increased selectivity toward NMU receptor 1 (NMUR1). Compound >7 possessed the highest NMUR1 selectivity (IC50 = 0.54 nM, selectivity ratio = 5313) together with an increased potency (EC50 = 3.7 nM), an 18% increase of the maximal effect at NMUR1, and a higher resistance against enzymatic degradation as compared to the native NMU-8. The development of a potent NMUR1 agonist with extended half-life could represent an attractive tool to further unveil the role of NMUR1 in NMU signaling.
机译:Neuromedin U(NMU)是一种多功能神经肽,其特征是在所有物种中均具有高度保守性。在这里,我们描述了基于截短的NMU-8的一组新颖的NMU-模拟物的合成。通过结合先前报道的修饰,进行了详细的结构-活性关系研究,旨在开发对NMU受体1(NMUR1)具有更高选择性的肽。化合物> 7 具有最高的NMUR1选择性(IC50 = 0.54 nM,选择性比= 5313)以及增强的效能(EC50 = 3.7 nM),在NMUR1处的最大作用增加了18%,并且与天然NMU-8相比,对酶促降解的抵抗力更高。具有延长的半衰期的强效NMUR1激动剂的开发可能是进一步揭示NMUR1在NMU信号传导中的作用的有吸引力的工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号